Worldwide Clinical Trials to Host Free Webinar on Improving Clinical Site Performance
MORRISVILLE, North Carolina, July 28, 2016 /PRNewswire/ --
Worldwide Clinical Trials will host a free webinar, titled "Improving Clinical Site Performance: It's All About Relationships," that explores the impact of relationships between sponsors, CROs and sites on clinical trial planning and execution.
Set for Thursday, Aug. 18 at 11 a.m. ET, the webinar will be hosted by Jeff Zucker, Worldwide's vice president of Feasibility and Recruitment Optimization. Zucker will be joined by guest speaker Woody Woodman, president & CEO of Synergy Clinical Research Centers.
"Relationships between a sponsor, CRO and trial sites can have a significant impact on achieving study success," explains Zucker. "During the webinar we'll discuss how effective relationships can be formed and maintained from trial start-up and recruitment through implementation, delving into new strategies for establishing and optimizing key connections. We'll also look at how sponsors and CROs can build and enhance site partnerships to optimize study execution."
To register for this free Worldwide Clinical Trials webinar, visit: http://go.worldwide.com/2016_Events_Webinar_Site_Performance_Webcast_Registration_LP.html.
Connect with Worldwide Clinical Trials:
- Tweet: @worldwidetrials explains how 'It's all about relationships' during free webinar: http://go.worldwide.com/2016_Events_Webinar_Site_Performance_Webcast_Registration_LP.htm
- Follow us on Twitter: @worldwidetrials
- Find us on LinkedIn: https://www.linkedin.com/company/worldwide-clinical-trials-inc-
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world's leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit http://www.Worldwide.com.
SOURCE Worldwide Clinical Trials